Hofman, I. J., Van Duin, M., De Bruyne, E., Fancello, L., Mulligan, G., Geerdens, E., . . . De Keersmaecker, K. (2016). RPL5 on 1p22.1 is recurrently deleted in multiple myeloma and its expression is linked to bortezomib response. Leukemia.
Παραπομπή Chicago StyleHofman, Isabel JF, et al. "RPL5 On 1p22.1 Is Recurrently Deleted in Multiple Myeloma and Its Expression Is Linked to Bortezomib Response." Leukemia 2016.
Παραπομπή MLAHofman, Isabel JF, et al. "RPL5 On 1p22.1 Is Recurrently Deleted in Multiple Myeloma and Its Expression Is Linked to Bortezomib Response." Leukemia 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.